OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia
Lola Peris, Néstor Szerman
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Lola Peris, Néstor Szerman
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Showing 12 citing articles:
Addictive and other mental disorders: a call for a standardized definition of dual disorders
Néstor Szerman, Marta Torrens, Rafaël Maldonado, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Néstor Szerman, Marta Torrens, Rafaël Maldonado, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Structure-guided design of partial agonists at an opioid receptor
Balázs R. Varga, Sarah M. Bernhard, Amal El Daibani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Balázs R. Varga, Sarah M. Bernhard, Amal El Daibani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, et al.
British Journal of Pharmacology (2025)
Open Access
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, et al.
British Journal of Pharmacology (2025)
Open Access
A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
Ewa Galaj, Guo‐Hua Bi, Benjamin Klein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 13, pp. 2309-2318
Open Access | Times Cited: 17
Ewa Galaj, Guo‐Hua Bi, Benjamin Klein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 13, pp. 2309-2318
Open Access | Times Cited: 17
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study
Ginevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
Ginevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Emma Gogarnoiu, Caleb D. Vogt, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1809-1834
Open Access | Times Cited: 5
Emma Gogarnoiu, Caleb D. Vogt, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1809-1834
Open Access | Times Cited: 5
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
Alexander Denissoff, Heidi Taipale, Jari Tiihonen, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
Alexander Denissoff, Heidi Taipale, Jari Tiihonen, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 1
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder
Néstor Szerman, Pablo Vega, Carlos Roncero, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
Néstor Szerman, Pablo Vega, Carlos Roncero, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
Management of schizophrenia and comorbid substance use disorders: expert review and guidance
Adrián Neyra, Carlos Parro-Torres, Elena Ros-Cucurull, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Adrián Neyra, Carlos Parro-Torres, Elena Ros-Cucurull, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series
Juan Duque-Yemail, Juan Carlos Avila
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1433-1440
Open Access | Times Cited: 7
Juan Duque-Yemail, Juan Carlos Avila
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1433-1440
Open Access | Times Cited: 7
On Complexity and Emergence: Linking the Hypotheses of Pharmacoresistance in Epilepsy
Gabriel Servilha‐Menezes, Alan Talevi, Norberto Garcia‐Cairasco
Springer eBooks (2023), pp. 39-62
Closed Access | Times Cited: 2
Gabriel Servilha‐Menezes, Alan Talevi, Norberto Garcia‐Cairasco
Springer eBooks (2023), pp. 39-62
Closed Access | Times Cited: 2
Structure-Guided Design of Partial Agonists at an Opioid Receptor
Tao Che, Balázs R. Varga, Sarah M. Bernhard, et al.
Research Square (Research Square) (2024)
Closed Access
Tao Che, Balázs R. Varga, Sarah M. Bernhard, et al.
Research Square (Research Square) (2024)
Closed Access
